| Esophageal Neoplasm altered in cohorts of …ALTERED_INderived136 of 136show fewer |
|---|
| ← altered in cohorts of | TP53 167 / 185 cases (90 %) · ssm · TCGA-ESCA · largest of 7 cohorts | — | — | Esophageal Carcinoma | 7 | Observed | gdc | graph → |
| ← altered in cohorts of | MYC 138 / 185 cases (75 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | POU5F1B 138 / 185 cases (75 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TG 138 / 185 cases (75 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KCNQ3 135 / 185 cases (73 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ADCY8 134 / 185 cases (72 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CDKN2A 134 / 185 cases (72 %) · ssm · TCGA-ESCA · largest of 3 cohorts | — | — | Esophageal Carcinoma | 3 | Observed | gdc | graph → |
| ← altered in cohorts of | GSDMC 134 / 185 cases (72 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LRATD2 134 / 185 cases (72 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CDKN2B 133 / 185 cases (72 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EFR3A 133 / 185 cases (72 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ASAP1 132 / 185 cases (71 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CCN4 132 / 185 cases (71 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HHLA1 132 / 185 cases (71 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KHDRBS3 132 / 185 cases (71 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LRRC6 132 / 185 cases (71 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NDRG1 132 / 185 cases (71 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | OC90 132 / 185 cases (71 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLA 132 / 185 cases (71 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TRIB1 132 / 185 cases (71 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZFAT 132 / 185 cases (71 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | COL22A1 131 / 185 cases (71 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CYRIB 131 / 185 cases (71 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PHF20L1 131 / 185 cases (71 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ST3GAL1 131 / 185 cases (71 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TMEM71 131 / 185 cases (71 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | WASHC5 131 / 185 cases (71 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF572 131 / 185 cases (71 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ACTRT3 130 / 185 cases (70 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | BCHE 130 / 185 cases (70 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CSMD3 130 / 185 cases (70 %) · ssm · TCGA-ESCA · largest of 5 cohorts | — | — | Esophageal Carcinoma | 5 | Observed | gdc | graph → |
| ← altered in cohorts of | DCC 130 / 185 cases (70 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LRRC31 130 / 185 cases (70 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LRRIQ4 130 / 185 cases (70 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NCEH1 130 / 185 cases (70 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NSMCE2 130 / 185 cases (70 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PDCD10 130 / 185 cases (70 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PIK3CA 130 / 185 cases (70 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SAMD7 130 / 185 cases (70 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SQLE 130 / 185 cases (70 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ATAD2 129 / 185 cases (70 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EIF5A2 129 / 185 cases (70 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM135B 129 / 185 cases (70 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FER1L6 129 / 185 cases (70 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FNDC3B 129 / 185 cases (70 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LRRC34 129 / 185 cases (70 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MRPL13 129 / 185 cases (70 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MTBP 129 / 185 cases (70 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MYNN 129 / 185 cases (70 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PHC3 129 / 185 cases (70 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PLEC 129 / 185 cases (70 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RNF139 129 / 185 cases (70 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RPL22L1 129 / 185 cases (70 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SEC62 129 / 185 cases (70 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SETBP1 129 / 185 cases (70 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SI 129 / 185 cases (70 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC14A1 129 / 185 cases (70 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC14A2 129 / 185 cases (70 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC2A2 129 / 185 cases (70 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC7A14 129 / 185 cases (70 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLITRK3 129 / 185 cases (70 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ST8SIA5 129 / 185 cases (70 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TNIK 129 / 185 cases (70 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ADGRB1 128 / 185 cases (69 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | AGO2 128 / 185 cases (69 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ARC 128 / 185 cases (69 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CLDN11 128 / 185 cases (69 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | COLEC10 128 / 185 cases (69 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DEPTOR 128 / 185 cases (69 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EPPK1 128 / 185 cases (69 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FBXO32 128 / 185 cases (69 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GML 128 / 185 cases (69 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GPR160 128 / 185 cases (69 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LOXHD1 128 / 185 cases (69 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LRRC14 128 / 185 cases (69 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ME2 128 / 185 cases (69 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MECOM 128 / 185 cases (69 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MELTF 128 / 185 cases (69 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MEX3C 128 / 185 cases (69 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MROH6 128 / 185 cases (69 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MTAP 128 / 185 cases (69 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MUC4 128 / 185 cases (69 %) · ssm · TCGA-ESCA · largest of 2 cohorts | — | — | Esophageal Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | NDUFB9 128 / 185 cases (69 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PLD1 128 / 185 cases (69 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PRKCI 128 / 185 cases (69 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RNF165 128 / 185 cases (69 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SERPINI1 128 / 185 cases (69 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SKIL 128 / 185 cases (69 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLURP2 128 / 185 cases (69 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SMAD4 128 / 185 cases (69 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TAF2 128 / 185 cases (69 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TATDN1 128 / 185 cases (69 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TMEM212 128 / 185 cases (69 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TNFSF10 128 / 185 cases (69 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TNK2 128 / 185 cases (69 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TRMT12 128 / 185 cases (69 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZBBX 128 / 185 cases (69 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF623 128 / 185 cases (69 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TTN 97 / 185 cases (52 %) · ssm · esca_tcga · largest of 6 cohorts | — | — | Esophageal Adenocarcinoma | 6 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC16 51 / 185 cases (28 %) · ssm · esca_tcga · largest of 5 cohorts | — | — | Esophageal Adenocarcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SYNE1 44 / 185 cases (24 %) · ssm · esca_tcga · largest of 4 cohorts | — | — | Esophageal Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH5 35 / 185 cases (19 %) · ssm · esca_tcga · largest of 3 cohorts | — | — | Esophageal Adenocarcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | HMCN1 34 / 185 cases (18 %) · ssm · esca_tcga · largest of 4 cohorts | — | — | Esophageal Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LRP1B 33 / 185 cases (18 %) · ssm · esca_tcga · largest of 4 cohorts | — | — | Esophageal Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FLG 32 / 185 cases (17 %) · ssm · esca_tcga · largest of 4 cohorts | — | — | Esophageal Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KMT2D 32 / 185 cases (17 %) · ssm · esca_tcga · largest of 4 cohorts | — | — | Esophageal Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RYR2 31 / 185 cases (17 %) · ssm · esca_tcga · largest of 3 cohorts | — | — | Esophageal Adenocarcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PCLO 29 / 185 cases (16 %) · ssm · esca_tcga · largest of 4 cohorts | — | — | Esophageal Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | USH2A 29 / 185 cases (16 %) · ssm · esca_tcga · largest of 2 cohorts | — | — | Esophageal Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CSMD1 27 / 185 cases (15 %) · ssm · esca_tcga · largest of 4 cohorts | — | — | Esophageal Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | OBSCN 27 / 185 cases (15 %) · ssm · esca_tcga | — | — | Esophageal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CNTN6 22 / 151 cases (15 %) · ssm · esca_broad | — | — | Esophageal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PTPRD 22 / 151 cases (15 %) · ssm · esca_broad | — | — | Esophageal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PKHD1L1 26 / 185 cases (14 %) · ssm · esca_tcga · largest of 2 cohorts | — | — | Esophageal Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LAMA1 21 / 151 cases (14 %) · ssm · esca_broad | — | — | Esophageal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FAT3 25 / 185 cases (14 %) · ssm · esca_tcga · largest of 3 cohorts | — | — | Esophageal Adenocarcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FAT4 25 / 185 cases (14 %) · ssm · esca_tcga · largest of 2 cohorts | — | — | Esophageal Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SPTA1 25 / 185 cases (14 %) · ssm · esca_tcga · largest of 3 cohorts | — | — | Esophageal Adenocarcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | APOB 20 / 151 cases (13 %) · ssm · esca_broad | — | — | Esophageal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC12 24 / 185 cases (13 %) · ssm · esca_tcga | — | — | Esophageal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DYNC2H1 23 / 185 cases (12 %) · ssm · esca_tcga | — | — | Esophageal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RYR3 23 / 185 cases (12 %) · ssm · esca_tcga | — | — | Esophageal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | XIRP2 23 / 185 cases (12 %) · ssm · esca_tcga | — | — | Esophageal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ADGRV1 22 / 185 cases (12 %) · ssm · esca_tcga | — | — | Esophageal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DST 22 / 185 cases (12 %) · ssm · esca_tcga | — | — | Esophageal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ATM 21 / 185 cases (11 %) · ssm · esca_tcga | — | — | Esophageal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | EYS 21 / 185 cases (11 %) · ssm · esca_tcga · largest of 2 cohorts | — | — | Esophageal Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NEB 21 / 185 cases (11 %) · ssm · esca_tcga | — | — | Esophageal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PCDH15 21 / 185 cases (11 %) · ssm · esca_tcga · largest of 2 cohorts | — | — | Esophageal Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | UNC13C 21 / 185 cases (11 %) · ssm · esca_tcga · largest of 2 cohorts | — | — | Esophageal Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZNF804B 21 / 185 cases (11 %) · ssm · esca_tcga | — | — | Esophageal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COL11A1 20 / 185 cases (11 %) · ssm · esca_tcga | — | — | Esophageal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LRRK2 20 / 185 cases (11 %) · ssm · esca_tcga | — | — | Esophageal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC17 20 / 185 cases (11 %) · ssm · esca_tcga | — | — | Esophageal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NBEA 20 / 185 cases (11 %) · ssm · esca_tcga | — | — | Esophageal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SYNE2 20 / 185 cases (11 %) · ssm · esca_tcga | — | — | Esophageal Adenocarcinoma | 1 | Observed | cbioportal | graph → |